Skip to content

Effect of Intraoperative Dextrose Infusion for Prevention of Nausea and Vomiting after Diagnostic Gynecologic Laparoscopy

Evaluating the Effect of Intraoperative Dextrose Infusion for Prevention of Nausea and Vomiting after Diagnostic Gynecologic Laparoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201402047013N10
Enrollment
70
Registered
2014-02-10
Start date
2013-12-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting. Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

Interventions

Treatment - Drugs
Intervention 1: In the study group is infused 10 ml/kg/h Ringer’s solution with 0.5 g/kg dextrose during surgery. Intervention 2: In the placebo group (n=35) is infused of 10 ml/kg/h Ringer’s solutio
Prevention
In the study group is infused 10 ml/kg/h Ringer’s solution with 0.5 g/kg dextrose during surgery.
In the placebo group (n=35) is infused of 10 ml/kg/h Ringer’s solution alone in placebo during surgery.

Sponsors

Research Vice Chancellor, Daneshgah Street, Tabriz
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Women aged 20-40 years; ASA class 1; scheduled for diagnostic gynecologic laparoscopy Exclusion criteria: vaginal hemorrhage; taking any medication, including corticosteroids , opioids and antiemetics; history of systemic disease( cardiovascular, respiratory, renal ,…); history of motion sickness; history of gastrointestinal disease; pregnancy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of postoperative nausea and vomiting. Timepoint: Recovery and at 3, 6, and 24 h postoperatively. Method of measurement: scoring by (0=non, 1=nausea, 2=vomiting, 3=vomiting >2 times).

Secondary

MeasureTime frame
Total dose of antiemetic. Timepoint: recavery and during 24 hpostoperatively. Method of measurement: mg.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Simin Atashkhoyi

Tabriz University of Medical Sciences

satashkhoyi@gmail.com siminatashkhoii@yahoo.com+98 41 1553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026